Skip to search boxSkip to navigationSkip to main content

Protein tyrosine kinases in neutrophil activation and recruitment

  • Alexander Zarbock(corresponding author)
    ,
*Corresponding author for this work
Scholary Output:
Contribution to journal
Article
Peer-review

Abstract

Migration of leukocytes into tissue is a key element of innate and adaptive immunity. The first contact of leukocytes with endothelial cells is mediated by engagement of selectins with their counter-receptors which results in leukocyte rolling. During rolling, leukocytes collect different inflammatory signals that activate intracellular signaling pathways. Integration of these signals induces leukocyte activation, firm arrest, post-adhesion strengthening, intravascular crawling, and transmigration. In neutrophils, like in T-cells and platelets, both G-protein-coupled receptor-dependent and -independent activation pathways exist that lead to integrin activation. Accumulating evidence suggests that different protein tyrosine kinases play key roles in signal transduction pathways regulating neutrophil activation and recruitment to inflammatory sites. This review focuses on the role of protein tyrosine kinases of the Src, Syk, and Tec families for neutrophil activation and recruitment.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 112-119 (8 pages)

Journal (Volume, Issue Number)

Archives of Biochemistry and Biophysics (Volume 510, Issue 2)

Publication milestones

  • Published - 06/15/2011

Publication status

Published - 06/15/2011

ISSN

0003-9861

Publication IDs

  • Scopus: 79958724618

Publication metrics

Metrics

Scopus
citations
Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Citation count
35
Captures
58

Funding Details

A.Z. is supported by grants from the German Research Foundation (DFG AZ 428/3-1, AZ 428/5-1) and the Interdisciplinary Clinical Research Center (IZKF, ZA2/001/10) (Muenster, Germany).